Galderma LabsArticles & NewsNewsGalderma and Cetaphil Announce New Clear Skies Initiative"As the leader in treating sensitive skin, it's time to be even more sensitive to the environment to contribute to both short-term and long-term change."NewsGalderma and Sofregen to Develop Silk-based Biostimulator FillersGalderma and Sofregen Medical have announced a co-development and option-to-acquire agreement for Sofregen’s Silk Voice.NewsGalderma Supports Breast Cancer Awareness MonthGalderma is partnering with the National Breast Cancer Foundation for the seventh year to provide education and support services to women.NewsMentor Joins Galderma ASPIRE Rewards ProgramMentor is now the first external collaborator for the ASPIRE Galderma Rewards Program.NewsGalderma Gains Exclusive Licenses for Acne and Rosacea TopicalsGalderma and Sol-Gel have announced two five-year license agreements for the commercialization of EPSOLAY and TWYNEO in the U.S., to treat rosacea and acne.InjectablesRestylane Kysse vs. Juvederm Volbella XC for Lip AugmentationRestylane Kysse was found to be noninferior to Juvederm Volbella XC for lip augmentation and perioral rhytids.
